Observational studySleep & breathing = Schlaf & Atmung2025
Predicting treatment success in pediatric mild-to-moderate OSA: real-world evidence from a model based on polysomnographic parameters.
Observational study in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric mild-to-moderate obstructive sleep apnea (OSA) is often treated with intranasal corticosteroids (INCS), but response rates vary. Identifying early predictors of treatment success may facilitate individualized therapy.
methodsWe conducted a single-center, two-phase observational study to develop and validate a predictive model for INCS response in children aged 3-12 years with mild-to-moderate OSA, defined by a baseline apnea-hypopnea index (AHI) of 1.0-10.0 events/hour. The derivation cohort (n = 175) was retrospectively enrolled between 2019 and 2023. A prospective validation cohort (n = 60) was recruited between 2024 and 2025 using identical diagnostic and treatment protocols. All patients received standardized INCS therapy. Treatment response was defined as a ≥ 50% reduction in AHI along with improvement in clinical symptoms at 6-9 months follow-up.
resultsCandidate predictors were extracted from baseline clinical and polysomnographic (PSG) parameters. Multivariable logistic regression was used to identify independent predictors. A predictive nomogram model was constructed based on these variables and externally validated in the prospective cohort. The model demonstrated good calibration and discrimination.
conclusionThis study presents a validated nomogram model based on PSG and clinical parameters to predict treatment response to INCS in pediatric OSA, supporting early decision-making and personalized treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.